I must say I was astonished to read the assessment (in the online journal PLos One) that well over half of pharma print ads to professionals are non-compliants with FDA guidelines.
Working for an agency that makes such materials, I do know that there is a rigorous review committee process by pharmaceutical company specialists to approve ads before
placing the marketplace. Thus a process exists for adhering to these guidelines among agencies and pharma companies, with the FDA regulations squarely in mind.
The findings are somewhat subjective, but this may introduce a cautionary note into the already existing process. Especially in light of the FDA "Bad Ad" program that so far has resulted in two warning letters.
